MANGOCEUTICALS, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 |
|---|---|---|---|---|
| Revenue | $456,021 | $615,873 | $731,493 | $8,939 |
| Gross profit | $250,386 | $379,964 | $431,501 | $4,850 |
| Operating income | -$18.0M | -$8.0M | -$9.2M | -$2.0M |
| Operating expenses | $18.3M | $8.4M | $9.7M | $2.0M |
| Cost of revenue | $54,422 | $93,296 | $154,900 | $4,089 |
| Cash from operations | -$5.9M | -$4.9M | -$7.0M | -$1.3M |
| Capital expenditure | — | — | $3,519 | $43,102 |
| Free cash flow | — | — | -$7.0M | -$1.4M |
| Impairments | — | $0 | $0 | — |
| Total assets | $16.1M | $15.4M | $1.1M | $1.0M |
| Total liabilities | $890,568 | $1.4M | $276,039 | $389,257 |
Shares outstanding 17.2M · Free float 88.4%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.